# Inhibrx Biosciences, Inc.: filings

INBX · Nasdaq · CIK 2007919 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inbx.md) · [Financials](/companies/inbx/financials.md) · [Filings](/companies/inbx/filings.md) · [Insiders](/companies/inbx/insiders.md)

## Reports and events: 43 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 45, 8-K 27, 424B3 11, 3 10, 10-Q 7, 144 5, SCHEDULE 13G/A 5, 4/A 4, CORRESP 3, EFFECT 3, UPLOAD 3, 10-12B/A 2, 10-K 2, ARS 2, DEF 14A 2, DEFA14A 2, POS AM 2, SC 13D 2, SC 13G 2, SCHEDULE 13D/A 2, 10-12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, POS EX 1, S-1 1, S-8 1, SCHEDULE 13G 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 21:03 ET | [8-K](/filings/0002007919-26-000050.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-26-000050 |
| 2026-09-08 | 20:01 ET | [8-K](/filings/0002007919-26-000047.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-26-000047 |
| 2026-08-13 | 20:10 ET | [8-K](/filings/0002007919-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-26-000044 |
| 2026-08-13 | 20:04 ET | [10-Q](/filings/0002007919-26-000042.md) | Quarterly report, period 2026-06-30 | 0002007919-26-000042 |
| 2026-07-16 | 20:06 ET | [8-K](/filings/0002007919-26-000037.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-26-000037 |
| 2026-06-15 | 20:06 ET | [8-K](/filings/0002007919-26-000033.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-26-000033 |
| 2026-06-03 | 20:02 ET | [8-K](/filings/0002007919-26-000030.md) | 5.07 Shareholder vote results | 0002007919-26-000030 |
| 2026-05-14 | 20:04 ET | [8-K](/filings/0002007919-26-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-26-000028 |
| 2026-05-14 | 20:02 ET | [10-Q](/filings/0002007919-26-000027.md) | Quarterly report, period 2026-03-31 | 0002007919-26-000027 |
| 2026-05-11 | 20:02 ET | [8-K](/filings/0002007919-26-000020.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-26-000020 |
| 2026-04-23 | 20:05 ET | [DEF 14A](/filings/0002007919-26-000014.md) | Proxy statement, period 2025-12-31 | 0002007919-26-000014 |
| 2026-04-21 | 20:04 ET | [8-K](/filings/0002007919-26-000010.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-26-000010 |
| 2026-03-19 | 20:01 ET | [8-K](/filings/0002007919-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-26-000007 |
| 2026-03-19 | 20:00 ET | [10-K](/filings/0002007919-26-000006.md) | Annual report, period 2025-12-31 | 0002007919-26-000006 |
| 2026-02-23 | 14:00 ET | [8-K](/filings/0002007919-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-26-000002 |
| 2025-12-16 | 22:00 ET | [8-K](/filings/0002007919-25-000097.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-25-000097 |
| 2025-11-14 | 23:00 ET | [8-K](/filings/0002007919-25-000094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-25-000094 |
| 2025-11-14 | 22:59 ET | [10-Q](/filings/0002007919-25-000093.md) | Quarterly report, period 2025-09-30 | 0002007919-25-000093 |
| 2025-10-23 | 20:05 ET | [8-K](/filings/0002007919-25-000089.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-25-000089 |
| 2025-08-13 | 20:06 ET | [8-K](/filings/0002007919-25-000083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-25-000083 |
| 2025-08-13 | 20:03 ET | [10-Q](/filings/0002007919-25-000081.md) | Quarterly report, period 2025-06-30 | 0002007919-25-000081 |
| 2025-05-28 | 20:03 ET | [8-K](/filings/0002007919-25-000063.md) | 5.07 Shareholder vote results | 0002007919-25-000063 |
| 2025-05-14 | 20:11 ET | [8-K](/filings/0002007919-25-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-25-000057 |
| 2025-05-14 | 20:09 ET | [10-Q](/filings/0002007919-25-000056.md) | Quarterly report, period 2025-03-31 | 0002007919-25-000056 |
| 2025-04-16 | 20:49 ET | [DEF 14A](/filings/0002007919-25-000043.md) | Proxy statement, period 2024-12-31 | 0002007919-25-000043 |
| 2025-04-01 | 20:13 ET | [8-K](/filings/0002007919-25-000028.md) | 5.02 Departure or appointment of officers or directors | 0002007919-25-000028 |
| 2025-03-17 | 20:09 ET | [8-K](/filings/0002007919-25-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-25-000020 |
| 2025-03-17 | 20:03 ET | [10-K](/filings/0002007919-25-000019.md) | Annual report, period 2024-12-31 | 0002007919-25-000019 |
| 2025-02-26 | 21:26 ET | [SCHEDULE 13D/A](/filings/0002007919-25-000015.md) | Ownership report, active investor, amended | 0002007919-25-000015 |
| 2025-02-26 | 21:16 ET | [SCHEDULE 13D/A](/filings/0002007919-25-000012.md) | Ownership report, active investor, amended | 0002007919-25-000012 |
| 2025-01-21 | 22:03 ET | [8-K](/filings/0002007919-25-000007.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002007919-25-000007 |
| 2025-01-13 | 21:18 ET | [8-K](/filings/0002007919-25-000003.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-25-000003 |
| 2024-11-14 | 21:25 ET | [8-K](/filings/0002007919-24-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002007919-24-000060 |
| 2024-11-14 | 21:02 ET | [10-Q](/filings/0002007919-24-000058.md) | Quarterly report, period 2024-09-30 | 0002007919-24-000058 |
| 2024-11-04 | 21:36 ET | [8-K](/filings/0002007919-24-000054.md) | 8.01 Other events | 0002007919-24-000054 |
| 2024-08-13 | 20:09 ET | [8-K](/filings/0002007919-24-000031.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-24-000031 |
| 2024-08-13 | 20:03 ET | [10-Q](/filings/0002007919-24-000029.md) | Quarterly report, period 2024-06-30 | 0002007919-24-000029 |
| 2024-06-17 | 20:03 ET | [8-K](/filings/0002007919-24-000016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002007919-24-000016 |
| 2024-06-11 | 21:11 ET | [S-1](/filings/0002007919-24-000011.md) | Registration statement | 0002007919-24-000011 |
| 2024-06-03 | 00:45 ET | [SC 13D](/filings/0000950142-24-001549.md) | Ownership report, active investor | 0000950142-24-001549 |
| 2024-06-03 | 00:43 ET | [SC 13D](/filings/0000950142-24-001548.md) | Ownership report, active investor | 0000950142-24-001548 |
| 2024-05-30 | 20:11 ET | [8-K](/filings/0001104659-24-066645.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-066645 |
| 2024-05-24 | 20:21 ET | [8-K](/filings/0001104659-24-065140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-065140 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.